Efficacy and Safety of Alirocumab Versus Ezetimibe Over 2 Years (From ODYSSEY COMBO II)
FCACC Member: Mahfouz El Shahawy, MD, MS, FACC, FACP, FESC, FASH, FSCCT, FASPC, FAHA
Florida Chapter, American College of Cardiology Orlando, FL 32803 877-793-8171 |